Babylon Holdings Ltd

Babylon Holdings Ltd. engages in the development of mobile phone based healthcare application. The firm provides information on possible medical condition, medical solutions and common treatments. It offers online doctor consultation, health check-up, and monitoring. The company was founded by Ali Parsa in 2013 and is headquartered in London, the United Kingdom.

Earnings data Q1 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Babylon Holdings Ltd. engages in the development of a mobile phone-based healthcare application. The firm provides information on possible medical conditions, medical solutions and common treatments. It offers online doctor consultation, health check-up, and monitoring. The company was founded by Ali Parsa in 2013 and is headquartered in London, the United Kingdom.

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange LLC (“NYSE” or “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the Class A ordinary shares of Babylon Holdings Limited (the “Company”) — ticker symbol BBLN — from the NYSE. Trading in the Company's Class A ordinary shares will be suspended immediately. On June 22, 2023, NYSE Regulation notified the Company of noncompliance with the continued listing standards in Sections 802.01B.

NYSE to Commence Delisting Proceedings Against Babylon Holdings Limited (BBLN)

AUSTIN, Texas & LONDON--(BUSINESS WIRE)--Babylon Holdings Limited (the “Company” or “Babylon”) (NYSE:BBLN) previously announced in its June 23, 2023 press release that the Company has received a proposal from AlbaCore Capital LLP ("AlbaCore") and MindMaze Group SA ("MindMaze") pursuant to which core operating subsidiaries of the Company would be transferred to MindMaze (the “Proposed Transaction”). The closing of the Proposed Transaction is expected in July 2023 and is subject to agreed documen.

Babylon Proceeds With Previously Announced Transaction and Announces the Receipt of Continued Listing Standards Notice from NYSE and Upcoming Delisting

AUSTIN, Texas & LONDON & LAUSANNE, Switzerland--(BUSINESS WIRE)--After a thorough exploration of strategic alternatives, Babylon Holdings Limited (NYSE: BBLN) (including its subsidiaries, “Babylon”) is pleased to provide an update on the recapitalization transaction, previously announced on May 10, following receipt of a proposal from AlbaCore Capital LLP on behalf of certain of its affiliates (“AlbaCore”) and MindMaze Group SA (“MindMaze”), and share that Babylon has selected the previously an.

Babylon Announces Update on Take Private Proposal

Babylon (NYSE: BBLN ) stock is falling on Wednesday after the health services company revealed earnings and a plan to go private. Starting with that earnings report, Babylon's diluted EPS came in at -$2.53.

Why Is Babylon (BBLN) Stock Down 57% Today?

Healthcare company Babylon Holdings Ltd.'s stock BBLN tumbled 42% premarket Wednesday, after it announced plans to go private with backup from AlbaCore Capital.

Babylon's stock tumbles 42% as it prepares to go private

AUSTIN, Texas & LONDON--(BUSINESS WIRE)--Babylon Holdings Limited (NYSE: BBLN) (“Babylon” or the “Company”) today announced its financial and operating results for the first quarter ended March 31, 2023. First Quarter Financial Results Comparison of the following financial results for the three months ended March 31, 2023, to the three months ended March 31, 2022: Total revenue was $311.1 million compared to $266.4 million, a 1.2x year-over-year increase of $44.7 million. This was primarily due.

Babylon Reports Q1 2023 Financial Results

AUSTIN, Texas & LONDON--(BUSINESS WIRE)--Babylon Holdings Limited (NYSE: BBLN) (including its subsidiaries, “Babylon”) is pleased to announce that it has entered into an amendment and restatement of its senior secured term loan facility with AlbaCore Capital LLP and certain of its affiliates (“AlbaCore”), dated March 9, 2023 (the “Bridge Facility Agreement”), for up to an additional $34.5 million in funding (the “Interim Funding”). This investment demonstrates AlbaCore's ongoing support to Baby.

Babylon Secures Financing and Plans to Implement a Take Private Transaction with Support from AlbaCore Capital

AUSTIN, Texas & LONDON--(BUSINESS WIRE)--Babylon (NYSE: BBLN) (the “Company”) today announced it will host a conference call to review its first quarter financial results on Wednesday, May 10, 2023, at 8:00 AM Eastern Time. A press release announcing the results will be issued prior to the conference call on Wednesday, May 10, 2023. To participate in the live conference call and webcast, please dial (877) 407-7994 for U.S. participants, 0 800 756 3429 for U.K.

Babylon Announces First Quarter 2023 Earnings Conference Call

AUSTIN, Texas & LONDON--(BUSINESS WIRE)--Babylon (NYSE: BBLN), a global digital healthcare company, announced today personalized, digital-first programs for high-risk members living with chronic conditions. The care pathways were developed hand-in-hand by Babylon's expert technologists and primary care teams for a true end-to-end value-based care system.

Babylon Announces Integrated Digital-First Chronic Condition Programs Offering Personalized Evidence-Based Care Within Single Interface

Babylon Holdings Limited (NYSE:BBLN ) Q4 2022 Earnings Conference Call March 9, 2023 8:00 AM ET Company Participants Ali Parsa - Founder and Chief Executive Officer David Humphreys - Chief Financial Officer Saurabh Johri - Chief Scientific Officer Conference Call Participants David Larsen - BTIG Allen Lutz - Bank of America Daniel Grosslight - Citi Richard Close - Canaccord Genuity Operator Hello, and welcome to Babylon's Fourth Quarter and Full Year 2022 Earnings Conference Call and Webcast. [Operator Instructions] Please note, this event is being recorded.

Babylon Holdings Limited (BBLN) Q4 2022 Earnings Call Transcript

AUSTIN, Texas & LONDON--(BUSINESS WIRE)--Babylon Holdings Limited (NYSE: BBLN) (“Babylon” or the “Company”) today announced its financial and operating results for the fourth quarter and fiscal year ended December 31, 2022. In 2022, Babylon's revenue grew 3.5x to $1.11 billion, exceeding guidance. The Company's most mature business, UK clinical services, achieved COCD profitability in 2022, and its U.S. clinical services business is expecting the same early this year. Babylon's U.S.

Babylon Reports Another Strong Year Exceeding Guidance, and Accelerates Expected Adjusted EBITDA Profitability to Mid-2024

AUSTIN, Texas & LONDON--(BUSINESS WIRE)-- #SmarterCareBetterHealth--Babylon (NYSE: BBLN) (the “Company”) today announced it will host a conference call to review its fourth quarter and full year 2022 financial results on Thursday, March 9, 2023, at 8:00 AM Eastern Time. A press release announcing the results will be issued prior to the conference call on Thursday, March 9, 2023. To participate in the live conference call and webcast, please dial (877) 407-7994 for U.S. participants, 0 800 756 3429 for U.K.

Babylon Announces Fourth Quarter and Full Year 2022 Earnings Conference Call

AUSTIN, Texas & LONDON--( BUSINESS WIRE )--Babylon Holdings Limited (NYSE: BBLN) (“Babylon” or the “Company”) today confirmed that its revenue for the year ended December 31, 2022 is expected to exceed $1.05 billion on both a U.S. GAAP and International Financial Reporting Standards (IFRS) basis, including revenue from the IPA business in California. Babylon also expects to beat its previous IFRS Adjusted EBITDA guidance of $(270) million or less for 2022. These financial results are preliminary, unaudited and subject to change in connection with the completion of Babylon's financial closing process and the preparation of its audited financial statements for 2022.

Babylon Delivers Strong 2022 Results, Beating Expectations

Today, we put digital healthcare concern Babylon Holdings Limited in the spotlight for the first time. Despite impressive revenue growth, the shares of this small cap company have been pummeled in the markets.

Babylon Holdings: A Fairy Tale Gone Bad

AUSTIN, Texas & LONDON--( BUSINESS WIRE )--Babylon (NYSE: BBLN) (“Babylon'') today announced additional details concerning the previously announced 1-for-25 reverse share split (the “Reverse Share Split") of its Class A ordinary shares, par value $0.0000422573245084686 per share (the “Class A Ordinary Shares”), which will become effective on December 15, 2022 (the “Effective Date”). These shares are expected to begin trading on a split-adjusted basis at market open on December 16, 2022.

Babylon Announces Additional Details on its Upcoming 1-for-25 Reverse Share Split

AUSTIN, Texas & KIGALI, Rwanda & LONDON--( BUSINESS WIRE )--Babyl, a subsidiary of Babylon (NYSE: BBLN), and Novo Nordisk announced today that they have entered an innovative partnership to contribute to the expansion of diabetes awareness and care in Rwanda. Drawing on Novo Nordisk's expertise and mission to drive change to defeat diabetes and Babyl's existing infrastructure and experience in delivering digital health services at scale in Rwanda, this new joint initiative aims to improve awareness, care and management of diabetes through community engagement, skills building and use of Babyl's advanced digital technology.

Babyl & Novo Nordisk partner to provide an innovative approach to diabetes awareness and care in Rwanda

AUSTIN, Texas--( BUSINESS WIRE )--Babylon (NYSE: BBLN) announced today that it will offer Fitbit devices and services to a subset of members that doesn't currently have access to wearables and that fit health program criteria to promote proactive management of care and improve accessibility through its digital-first offering.

Babylon to Provide Fitbits, Expand Access to Proactive Monitoring for Eligible Members

Babylon Holdings Limited (NYSE:BBLN ) Q3 2022 Earnings Conference Call November 10, 2022 8:00 AM ET Company Participants Ali Parsa - Founder and Chief Executive Officer David Humphreys - Chief Financial Officer Conference Call Participants David Larsen - BTIG Dev Weerasuriya - Berenberg Capital Daniel Grosslight - Citi Operator Good morning and welcome to Babylon's Third Quarter 2022 Earnings Conference Call and Webcast. [Operator Instructions] Leading the call today is Dr. Ali Parsa, Founder and Chief Executive Officer and David Humphreys, Chief Financial Officer.

Babylon Holdings Limited (BBLN) Q3 2022 Earnings Call Transcript

AUSTIN, Texas & LONDON--(BUSINESS WIRE)--Babylon Holdings Limited (NYSE: BBLN) (“Babylon”) today announced its financial and operating results for the third quarter ended September 30, 2022.

Babylon Reports Another Strong Quarter Ahead of Consensus Estimates with Revenue Growth of 3.9x and 45 ppts Adjusted EBITDA Margin Improvement

AUSTIN, Texas & LONDON--(BUSINESS WIRE)--Babylon (NYSE: BBLN) (“Babylon'') today announced that it is proceeding with a 1-for-25 reverse share split (the “Reverse Share Split") of its Class A ordinary shares, par value $0.0000422573245084686 per share (the “Class A Ordinary Shares”).

Babylon Announces 1-for-25 Reverse Share Split

AUSTIN, Texas & LONDON--(BUSINESS WIRE)-- #openenrollment--Almost half (46%) of Americans surveyed admit healthcare bills have put them in debt, according to new research conducted on behalf of Babylon (NYSE: BBLN), a global digital-first healthcare company, whose mission is to make high-quality healthcare accessible and affordable for everyone.

Almost Half of Americans Surveyed Admit Healthcare Bills Have Put Them in Debt

AUSTIN, Texas & WASHINGTON & LONDON--(BUSINESS WIRE)--Population Services International (PSI) announced the launch of a new digital health service in Vietnam to help people in low-income communities make informed decisions about their health and efficiently navigate the healthcare system.

Population Services International (PSI) Partners With Babylon to Launch New Digital Service for Low-income Populations in Vietnam

A dilutive capital-raising measure isn't making investors happy, to put it gently.

Why Babylon Holdings Stock Plummeted by 15% Today

AUSTIN, Texas & LONDON--(BUSINESS WIRE)--Babylon (NYSE: BBLN) (“Babylon'' or the “Company”) today announced that it has received its Board of Directors' authorized maximum of $80 million in total subscriptions (the “Subscriptions”) from institutional and other accredited investors for its previously announced private investment in public equity (the “PIPE”) at a price of $0.42122 per Class A ordinary share.

Babylon Receives $80 Million in Total Subscriptions for Private Placement Financing

AUSTIN, Texas & LONDON--(BUSINESS WIRE)--Babylon (NYSE: BBLN) (“Babylon'' or the “Company”) today announced that it has agreed to sell an aggregate of 145,885,760 (prior to rounding of fractional shares) of its Class A ordinary shares to certain institutional and other accredited investors (the “Initial Subscribers”) in a private investment in public equity (the “PIPE”) at a price of $0.42122 per share (the “Initial Subscriptions”).

News for Babylon Holdings Ltd Stock (BBLN)